Neurocrine Biosciences, Inc. (NBIX)

NASDAQ: NBIX · Real-Time Price · USD

129.78

+2.00 (1.57%)

At close: Mar 13, 2026, 4:00 PM EDT

128.05

-1.73 (-1.33%)

After-hours: Mar 13, 2026, 5:41 PM EDT

Neurocrine Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	713	233	251.1	262.9	340.8
Short-Term Investments	767.4	843.1	780.5	726.4	370.5
Cash & Short-Term Investments	1,480	1,076	1,032	989.3	711.3
Cash Growth	37.57%	4.31%	4.28%	39.08%	-11.20%
Accounts Receivable	686.8	479.1	439.3	350	185.5
Inventory	69	57.4	38.3	35.1	30.5
Other Current Assets	219.2	179.4	97.8	79.1	45.5
Total Current Assets	2,523	1,725	1,607	1,454	972.8
Net Property, Plant & Equipment	545.2	592	347.3	145.6	155.8
Other Intangible Assets	-	-	35.5	37.2	-
Long-Term Investments	1,184	864.3	849.4	401.5	624.4
Other Long-Term Assets	379.8	537.7	412.2	330.9	319.5
Total Assets	4,632	3,719	3,251	2,369	2,073
Accounts Payable	674.3	461.6	448.8	347.6	225.8
Current Portion of Long-Term Debt	-	-	170.1	169.4	-
Other Current Liabilities	69.1	46.1	35.9	20.7	20
Total Current Liabilities	743.4	507.7	654.8	537.7	245.8
Long-Term Debt	-	-	-	-	335.1
Long-Term Leases	415.3	455.1	258.3	93.5	105.3
Other Long-Term Liabilities	219.7	166.2	106.3	29.7	12.3
Total Long-Term Liabilities	635	621.3	364.6	123.2	452.7
Total Liabilities	1,378	1,129	1,019	660.9	698.5
Common Stock	0.1	0.1	0.1	0.1	0.1
Additional Paid-in Capital	2,792	2,555	2,382	2,122	2,011
Accumulated Other Comprehensive Income	13.1	5.8	7	-7.9	-1.7
Retained Earnings	447.7	29.2	-157.1	-406.8	-635.8
Shareholders' Equity	3,253	2,590	2,232	1,708	1,374
Total Liabilities & Equity	4,632	3,719	3,251	2,369	2,073
Total Debt	415.3	455.1	428.4	262.9	440.4
Net Cash (Debt)	1,065	621	603.2	726.4	270.9
Net Cash Growth	71.51%	2.95%	-16.96%	168.14%	-30.31%
Net Cash Per Share	10.39	5.99	5.97	7.34	2.77
Book Value	3,253	2,590	2,232	1,708	1,374
Book Value Per Share	31.74	24.97	22.10	17.27	14.03
Tangible Book Value	3,253	2,590	2,197	1,671	1,374
Tangible Book Value Per Share	31.74	24.97	21.75	16.89	14.03

Updated Feb 11, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q